As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Pankaj Patel, Chairman, Zydus Lifesciences; Umang Vohra, CEO, Cipla; G V Prasad, Co-Chairman, Dr Reddy's; Nilesh Gupta, MD, Lupin and Dilip Shanghvi, MD, Sun Pharmaceuticals sharing their vision to outline the roadmap for the industry.
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Subscribe To Our Newsletter & Stay Updated
